Rankings
▼
Calendar
AUPH Q3 2023 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$55M
-2.3% YoY
Gross Profit
$48M
87.6% margin
Operating Income
-$16M
-29.8% margin
Net Income
-$13M
-24.7% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+31.4%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$555M
Total Liabilities
$163M
Stockholders' Equity
$392M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$55M
$56M
-2.3%
Gross Profit
$48M
$53M
-10.5%
Operating Income
-$16M
-$9M
-71.2%
Net Income
-$13M
-$9M
-49.6%
Revenue Segments
Product
$41M
75%
License, Royalty and Collaboration Revenue
$14M
25%
← FY 2023
All Quarters
Q4 2023 →